Unavailable · 11.08.2026
Supply shortage: Neodolpasse – Infusionslösung
Affected country: Austria · Reported period: 11.08.2026 – not specified · Active ingredient: Diclofenac; Orphenadrin
Notice context
A supply shortage has been recorded for Neodolpasse – Infusionslösung in Austria. The stated reason is “Distribution restriction”. The notice concerns the active ingredient Diclofenac; Orphenadrin and is not identified as hospital-relevant.
This information describes the reported supply status and is not medical or pharmaceutical treatment advice. Availability, alternatives and further measures must be assessed for each individual case by the responsible pharmaceutical market participants.
Official shortage notice for Austria. Responsibility and update procedures follow the information supplied by the relevant authority.
Check the official notice list →